GSK Pharma Uploads Analyst Meeting Recording

• The document is an intimation regarding an Analyst/Institutional Investor Meet.
• A recording of the meeting has been uploaded.
• The date of the disclosure is 4th November 2026.
• The stated purpose of the event is not detailed in the provided text.
• The specific date and time of the original meeting are not mentioned.
• Management participants and their designations are not provided.
• The audio recording is available at: https://india-pharma.gsk.com/en-in/investors/analyst-meets/
• The disclosure is made pursuant to Regulation 30 read with Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Additional Notes Section

• The disclosure is a compliance letter addressed to BSE Limited and The National Stock Exchange of India Limited.
• It is signed by Ajay Nadkarni, Vice President – Administration, Real Estate & Company Secretary.
• The company's Corporate Identification Number (CIN) is provided: L24239MH1924PLC001151.
• No financial data, guidance, or strategic updates were disclosed in this announcement.